Hi, we've made some changes

Acambis(ACM)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Small Cap

Market Cap

£161.51m

Change Today

Price Down-0.75p

Share Price

111.00p

Acambis Overview

Biotechnology group, Acambis, develops vaccines to combat infectious disease. It hit the headlines after September 11 as demand for its smallpox vaccines from governments worldwide rocketed.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -340.0% -128.3%
ROCE -132.4%  

Valuation

Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 17.0 9.1
Pr/Book 4.6  

Growth

Latest F'cast
Revenue -69.3% 86.7%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Acambis Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-03 a169.10 a39.60 34.70p 8.8 0.0 +247% n/a 0.0%
31-Dec-04 85.50 27.00 18.50p 13.6 n/a -47% n/a 0.0%
31-Dec-05 40.90 (27.70) (25.20)p n/a n/a n/a n/a 0.0%
31-Dec-06 30.90 (15.90) (15.40)p n/a n/a n/a n/a 0.0%
31-Dec-07 9.50 (31.30) (29.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Acambis Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 17.73 (22.75) (16.13)p n/a n/a n/a n/a 0.0%
31-Dec-09 18.96 (27.01) (18.17)p n/a n/a n/a n/a 0.0%

Covering analysts: Blue Oar Securities, Credit Suisse, Goldman Sachs, Landsbanki Securities, Lehman Bros, Merrill Lynch, UBS

Acambis Company Announcements

Blocklisting Interim Review 03-Jul-2008 16:17 RNS
Total Voting Rights 30-Jun-2008 15:46 RNS
Annual Information Update 26-Jun-2008 14:45 RNS

Acambis ShareCast News

London close: Miners and oils lift Footsie 19-May-2008 ShareCast
Small caps round-up: AG Barr, Ocean Power, Kiwar... 19-May-2008 ShareCast
London close: Late rally helps Footsie 23-Apr-2008 ShareCast

Acambis Top Newspaper Links

US government smallpox vaccine contract for Acam... 24-Apr-2008 Telegraph
Acambis signs deal with Sanofi on West Nile vacc... 14-Nov-2007 The Scotsman
British firm cuts Baxter link to vaccine 24-May-2007 Chicago Tribune

Latest Acambis Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Acambis Market Data

Currency UK Pounds
Share Price 111.00p Price Down
Change Today -0.75p
52 Week High 138.50p
52 Week Low 105.00p
Volume 335,264
Shares Issued 145.51m
Market Cap £161.51m
Beta 0.21
RiskGrade 131

Acambis Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.13% below the market average46.13% below the market average46.13% below the market average46.13% below the market average46.13% below the market average
58.02% below the sector average58.02% below the sector average58.02% below the sector average58.02% below the sector average58.02% below the sector average
Price Trend
19.40% above the market average19.40% above the market average19.40% above the market average19.40% above the market average19.40% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average
Income Not Available
Growth
70.81% below the market average70.81% below the market average70.81% below the market average70.81% below the market average70.81% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 2
Buy 3
Neutral 1
Sell 0
Strong Sell 1
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Acambis Dividends

No dividends found

Trades for 18-Jul-2008

Time Volume / Share Price
16:35 14,797 @ 111.00p
16:08 102 @ 109.75p
16:08 1,925 @ 109.50p
15:43 171 @ 109.50p
15:43 320 @ 109.50p

Acambis Key Personnel

CEO Ian Garland
CFO Elizabeth Jones

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).